London, England, United Kingdom In 2009 was created ViiV Healthcare, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the London. The venture was found in Europe in United Kingdom.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2010. Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2004.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Health Care. Among the most popular portfolio startups of the fund, we may highlight Idenix Pharmaceuticals. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 1 partaker. In the next rounds fund is usually obtained by The Baupost Group.
| Fund Name | Location |
| 451 Media Group | New York, New York, United States |
| ACPL Exports | Agra, India, Uttar Pradesh |
| Bicameral Ventures | Canada, Ontario, Toronto |
| D Ventures Private Investment Fund | - |
| High Meadows Foundation | - |
| Macif | France, Ile-de-France, Paris |
| Money Forward Venture Partners | Japan, Tokyo |
| Shanghai Jinjiu Liangchen Investment Management | China, Shanghai |
| Venture Management | Madison, United States, Wisconsin |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 